Skip to main content
. 2005 Jun;166(6):1619–1628. doi: 10.1016/S0002-9440(10)62472-8

Figure 2.

Figure 2

MMP expression in cardiac myxomas evaluated by Western blot analysis. A: Pro-MMP-2, pro-MMP-9, pro-MT1-MMP, and TIMP-2 content is increased in embolic as compared to nonembolic myxomas. B: Densitometric blot analysis in uOD values confirms that MMP expression is increased in embolic as compared to nonembolic myxomas; results are given as means ± SEM; *P < 0.05 and **P < 0.002 versus nonembolic myxomas Ca, control mammary carcinoma.